Results 31 to 40 of about 52,316 (242)
Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta +3 more
wiley +1 more source
Pharmacy Matters - October 2021 [PDF]
Featured stories: Pharmacy Graduate Students Win AAPS Student Chapter Award, Stellar Student: Hyllore Imeri, Pharmacology Graduate Student Striving for Excellencehttps://egrove.olemiss.edu/pharmacy_newsletters/1101/thumbnail ...
University of Mississippi. School of Pharmacy
core +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
A pilot programme to teach pharmacology using the i nternational nonproprietary names in a pharmacy school in Spain [PDF]
Introduction: In pharmacology lectures, one of the major challenges faced by students is how students can remember an increasing list of a large number of drug names.
Duran, Màrius +4 more
core +1 more source
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin +12 more
wiley +1 more source
Lactoferrin promotes wound healing by activating MAPK, PI3K/Akt, and extracellular matrix pathways, enhancing fibroblast remodeling, proliferation, and re‐epithelialization. These mechanisms highlight its therapeutic potential in inflammation control, tissue repair, and remodeling.
Morgana Lüdtke Azevedo +4 more
wiley +1 more source
Kaiyang Wang,1,* Huhai Zhang,2,* Lie Yuan,3,4 Xiaoli Li,3,4 Yongqing Cai1 1Department of Pharmacy, Daping Hospital, Army Medical University, Chongqing, People’s Republic of China; 2Department of Nephrology, Southwest Hospital, Army Medical ...
Wang K, Zhang H, Yuan L, Li X, Cai Y
doaj
TGF‐β1 stimulation downregulates lysosomal channel TRPML1 in pulmonary fibroblasts. The TRPML1 agonist ML‐SA5 suppressed fibroblast‐to‐myofibroblast activation and collagen production. Mechanistically, ML‐SA5 inhibited mTOR phosphorylation, restored autophagic flux, and its effects were enhanced by rapamycin (mTOR inhibitor) and reversed by MHY1485 ...
Jiatong Yao +10 more
wiley +1 more source
The chair of pharmacology, faculty of pharmacy of the I.M. Sechenov First MSMU formed the Moscow school of teaching pharmacology at the Institute of Pharmacy and Pharmaceutical Institute, is a prestigious scientific pharmaceutical center.
A. A. Svistunov, N. P. Bykov
doaj
Cover, Content, and Editorial Note from Borneo J Pharm Vol. 2 No. 2 November 2019
Alhamdulillahirabbil ‘alamin. The next edition of Borneo Journal of Pharmacy (Borneo J Pharm), has been published at November 2019. Starting from this edition, Borneo J Pharm make changes to the template in the article that will be published.
Chief Editor of Borneo J Pharm
doaj +1 more source

